FDA Fast-Tracks Serono's Oral MS Drug
624821
NEW YORK -- Swiss biotech firm Serono SA, which earlier Thursday agreed to sell a majority stake in the company to German drugmaker Merck KGaA for $13.31 billion, said its oral cladribine treatment for multiple sclerosis has received "fast-track" status from the U.S. Food and Drug Administration.
589764
Viagra, Oxycontin and some AIDS (news - web sites) drugs will be among the first to carry radio chip tracking devices under a new Food
751178
ZURICH/FRANKFURT  - German drugmaker Merck KGaA   MRCG.DE on Thursday unveiled a surprise 16.6-billion-Swiss   franc ($13.26-billion) deal to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
156434
An experimental cancer drug made by Abbott Laboratories Inc. passed its first round of human testing about six months faster than usual, thanks to a new program that aims to speed drug development.
498388
German drug maker Schering AG (SCHG.DE: Quote , Profile , Research ) was boosted on Thursday as the U.S. Food and Drug Administration granted its Bonefos treatment "priority review" for preventing bone tumours ...
116025
WASHINGTON The Food and Drug Administration has ordered a sweeping review of studies involving prescription painkillers like Celebrex and Bextra.
113986
The Food and Drug Administration strongly endorsed Biogen Idec Inc.&#39;s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share.
384223
The US Food and Drug Administration has approved the first over-the-counter diet drug, a lower dose version of a prescription drug made by British firm GlaxoSmithKline.
313927
The U.S. Food and Drug Administration on Wednesday ordered sleep disorder drugs to carry stronger warnings about their risks, such as drowsy driving and severe allergic reactions.
733890
NEW YORK, NOVEMBER 25: The Federal Government has just approved a new medicine for multiple sclerosis that doctors say represents a new treatment approach that will significantly reduce the frequency of disabling episodes.
287736
TORONTO - A new but potentially costly treatment for multiple sclerosis has received fast-track approval from the US Food and Drug Administration.
583059
LONDON, October 6  - AstraZeneca (AZN.ISE) has delayed the regulatory approval filing target for its diabetes drug, Galida, from 2006 to 2007, while admitting that its anti-blood clotting drug, Exanta, was unlikely to receive the US
18405
The Food and Drug Administration on Tuesday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
103386
A U.S. Food and Drug Administration preliminary analysis found a level of heart-attack risk with GlaxoSmithKline Plc's  diabetes drug Avandia similar to what was reported in a study earlier this week, the agency confirmed on Friday.
192897
WASHINGTON Oct. 13, 2004 - The Food and Drug Administration on Wednesday approved an implantable computer chip that can pass a patient&#39;s medical details to doctors, speeding care.
150048
The Food and Drug Administration will establish a new independent Drug Safety Oversight Board to monitor FDA-approved medicines once they're on the market and update physicians and patients with emerging information on risks and benefits.
404405
Dr. Steven Galson, acting director of the Food and Drug Administration&#39;s Center for Drug Evaluation, announced Friday that the FDA will review five popular drugs whose safety is being questioned.